tiprankstipranks
Trending News
More News >
Q-linea AB (DE:3F8)
FRANKFURT:3F8

Q-linea AB (3F8) Price & Analysis

Compare
0 Followers

3F8 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

100.00%
Insiders
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

3F8 FAQ

What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
    What is Q-linea AB’s market cap?
    Q-linea AB’s market cap is €31.97M.
      When is Q-linea AB’s upcoming earnings report date?
      Q-linea AB’s upcoming earnings report date is Jul 10, 2025 which is in 11 days.
        How were Q-linea AB’s earnings last quarter?
        Q-linea AB released its earnings results on Apr 14, 2025. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
          Is Q-linea AB overvalued?
          According to Wall Street analysts Q-linea AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Q-linea AB pay dividends?
            Q-linea AB does not currently pay dividends.
            What is Q-linea AB’s EPS estimate?
            Q-linea AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Q-linea AB have?
            Q-linea AB has 6,430,039,600 shares outstanding.
              What happened to Q-linea AB’s price movement after its last earnings report?
              Q-linea AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Q-linea AB?
                Currently, no hedge funds are holding shares in DE:3F8

                Company Description

                Q-linea AB

                Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
                Similar Stocks
                Company
                Price & Change
                Follow
                SciBase Holding AB
                Clinical Laserthermia Systems AB Class B
                SpectraCure AB
                Luxbright AB
                Acarix AB
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis